The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty

Journal of Arthroplasty

Volumn 29, Issue 2, 2014, Pages 387-389

  Wind, Tyler C ^a   Barfield, William R ^b,c   Moskal, Joseph T ^a  

^a CARILION CLINIC   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Department of Teacher Education and Department of Sociology and Anthropology   (United States)

Author keywords

Antifibrinolytics; Blood loss; Total hip arthroplasty; Tranexamic acid; Transfusion rate

Indexed keywords

TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; DEEP VEIN THROMBOSIS; DRUG EFFECT; DRUG INDICATION; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; VERY ELDERLY;

ANTIFIBRINOLYTICS; BLOOD LOSS; TOTAL HIP ARTHROPLASTY; TRANEXAMIC ACID; TRANSFUSION RATE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; TRANEXAMIC ACID; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892523472     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.05.026     Document Type: Article

References (36)

1. Sukeik M., Alshryda S., Haddad F.S., et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011, 93-B(1):39.
2. Lemair R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 2008, 90-B:1128.
3. Kumar A. Perioperative management of anemia: limits of blood transfusion and alternatives to it. Cleve Clin J Med 2009, 76(4):112.
4. Cardone D., Klein A.A. Perioperative blood conservation. Eur J Anaesthesiol 2009, 26:722.
5. Shander A., Hofmann A., Ozawa S., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010, 50(4):753.
6. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81(1):2.
7. Kazemi S.M., Mosaffa F., Eajazi A., et al. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics 2010, 33(1):17.
8. Prentice CR. Basis of antifibrinolytic therapy. J Clin Pathol Suppl (R Coll Pathol) 1980;14:35.
9. Mannucci P.M. Hemostatic drugs. N Engl J Med 1998, 229(4):245.
10. Shore-Lesserson L., Reich D.L., Vela-Cantos F., et al. Tranexamic acid reduces transfusion and mediastinal drainage in repeat cardiac surgery. Anesth Analg 1996, 83:18.
11. Colomina M.G., Bago J., Vidal X., et al. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid. Orthopedics 2009, 32(2):91.
12. Hanery D.A., Carless P.A., Moxey A.J., et al. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007, 4. CD001886.
13. Ickx B.E., van der Linden P.J., Melot C., et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Transfusion 2006, 46(4):595.
14. Henry D., Carless P., Fergusson D., et al. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009, 180(2):183.
15. Dalmau A., Sabate A., Acosta F., et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg 2000, 91(1):29.
16. Kagoma Y.K., Crowther M.A., Douketis J., et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 1223(5):687.
17. Fahmy N.R., Patel D.G. Hemostatic changes and post-operative deep-vein thrombosis associated with use of a pneumatic tourniquet. J Bone Joint Surg Am 1982, 63-A:461.
18. Dahl O.E. The role of pulmonary circulation in the regulation of coagulation and fibrinolysis in relation to major surgery. J Cardiothorac Vasc Anesth 1997, 11:322.
19. Rajesparan K., Biant L.C., Ahmad M., et al. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 2009, 91-B:776.
20. Ekback G., Axelsson K., Ryttberg L., et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000, 91:1124.
21. Claeys M.A., Vermeersch N., Haentjens P. Reduction of blood loss with tranexamic acids in primary total hip replacement surgery. Acta Chir Belg 2007, 107:397.
22. Ido K., Neo M., Asada Y., et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 2000, 120:518.
23. Niskanen R.O., Kokala O.L. Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop 2006, 76:829.
24. Garneti N., Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty 2004, 19:488.
25. Benoni G., Lethagen S., Nilsson P., et al. Tranexamic acid, given at the end of the operation, does not reduce posteropative blood loss in hip arthroplsty. Acta Orthop Scand 2000, 71:250.
26. Benoni G., Fredin H., Knebel R., et al. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001, 72:442.
27. Husted H., Blond L., Sonne-Holm S., et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 2003, 74:665.
28. Johansson T., Pettersson L.G., Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop 2005, 76:314.
29. Lemay E., Guay J., Cote C., et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 2004, 51:31.
30. Yamasaki S., Masuhara K., Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop 2004, 28:69.
31. Singh J., Ballal M.S., Mitchell P., et al. Effects of tranexamic acid on blood loss during total hip arthroplasty. J Orthop Surg 2010, 18(3):282.
32. Gill J.B., Rosenstein A. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis. J Arthroplasty 2006, 21(6):869.
33. Ho K.M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003, 31:529.
34. Ralley F.E., Berta D., Binns V., et al. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 2010, 468:1905.
35. Yamasaki S., Masuhara K., Fuji T. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg Am 2005, 87(4):766.
36. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet 2010, 376:23. CRASH-2 trial collaborators, m) 1999;81(1):2.